RU99128026A - NEW SALT - Google Patents
NEW SALTInfo
- Publication number
- RU99128026A RU99128026A RU99128026/04A RU99128026A RU99128026A RU 99128026 A RU99128026 A RU 99128026A RU 99128026/04 A RU99128026/04 A RU 99128026/04A RU 99128026 A RU99128026 A RU 99128026A RU 99128026 A RU99128026 A RU 99128026A
- Authority
- RU
- Russia
- Prior art keywords
- salt
- treatment
- prevention
- organic solvent
- aqueous organic
- Prior art date
Links
- 150000003839 salts Chemical class 0.000 title claims 11
- 239000011780 sodium chloride Substances 0.000 title claims 11
- 201000010099 disease Diseases 0.000 claims 8
- 230000002265 prevention Effects 0.000 claims 7
- 238000004519 manufacturing process Methods 0.000 claims 6
- RJKBBWHBNIPMCB-UHFFFAOYSA-N N',N'-di(cyclobutyl)-8-fluoro-3,4-dihydro-2H-chromene-5-carbohydrazide Chemical compound C1=2CCCOC=2C(F)=CC=C1C(=O)NN(C1CCC1)C1CCC1 RJKBBWHBNIPMCB-UHFFFAOYSA-N 0.000 claims 4
- 239000003960 organic solvent Substances 0.000 claims 4
- 210000003169 Central Nervous System Anatomy 0.000 claims 3
- FEWJPZIEWOKRBE-JCYAYHJZSA-L L-tartrate(2-) Chemical compound [O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O FEWJPZIEWOKRBE-JCYAYHJZSA-L 0.000 claims 3
- 230000002378 acidificating Effects 0.000 claims 3
- 206010002855 Anxiety Diseases 0.000 claims 2
- 206010012378 Depression Diseases 0.000 claims 2
- 206010046543 Urinary incontinence Diseases 0.000 claims 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims 2
- 230000000875 corresponding Effects 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 230000000694 effects Effects 0.000 claims 2
- 239000011356 non-aqueous organic solvent Substances 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 239000003727 serotonin 1A antagonist Substances 0.000 claims 2
- FEWJPZIEWOKRBE-JCYAYHJZSA-N (+)-tartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 claims 1
- 206010057666 Anxiety disease Diseases 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 claims 1
- 230000036506 anxiety Effects 0.000 claims 1
- 239000000969 carrier Substances 0.000 claims 1
- 238000002425 crystallisation Methods 0.000 claims 1
- 230000005712 crystallization Effects 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 229940079593 drugs Drugs 0.000 claims 1
- 238000010438 heat treatment Methods 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 238000001953 recrystallisation Methods 0.000 claims 1
- 238000002791 soaking Methods 0.000 claims 1
- 239000002904 solvent Substances 0.000 claims 1
- 230000001225 therapeutic Effects 0.000 claims 1
Claims (19)
i) растворение (R)-3-N, N-дициклобутиламино-8-фтор-3,4-дигидро-2Н-1-бензопиран-5-карбоксамида в соответствующем растворителе, необязательно, при нагревании,
ii) добавление (2R,3R)-винной кислоты, соответственно растворенной в подходящем водном органическом растворителе или неводном органическом растворителе,
iii) выдержка полученного раствора на холоде для кристаллизации,
iv) необязательно, перекристаллизация в подходящем водном органическом растворителе, если на стадии ii) используют неводный органический растворитель, с получением соли, определенной в п.2 или 3.15. The method of obtaining salt specified in any of paragraphs.1 to 3, characterized by the following sequentially performed steps:
i) dissolving (R) -3-N, N-dicyclobutylamino-8-fluoro-3,4-dihydro-2H-1-benzopyran-5-carboxamide in an appropriate solvent, optionally, with heating,
ii) adding (2R, 3R) -tartaric acid, respectively dissolved in a suitable aqueous organic solvent or non-aqueous organic solvent,
iii) soaking the solution obtained in the cold for crystallization,
iv) optionally, recrystallization in a suitable aqueous organic solvent, if in step ii) a non-aqueous organic solvent is used to obtain the salt as defined in claim 2 or 3.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9702066-3 | 1997-05-30 | ||
SE9702066A SE510305C2 (en) | 1997-05-30 | 1997-05-30 | Fresh salt |
Publications (2)
Publication Number | Publication Date |
---|---|
RU99128026A true RU99128026A (en) | 2001-09-27 |
RU2193560C2 RU2193560C2 (en) | 2002-11-27 |
Family
ID=20407187
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU99128026/04A RU2193560C2 (en) | 1997-05-30 | 1998-05-15 | Novel salt |
Country Status (34)
Country | Link |
---|---|
US (2) | US6858645B2 (en) |
EP (1) | EP0984952B1 (en) |
JP (1) | JP3554338B2 (en) |
KR (1) | KR20010013127A (en) |
CN (1) | CN1198814C (en) |
AR (1) | AR012751A1 (en) |
AT (1) | ATE228121T1 (en) |
AU (1) | AU729301B2 (en) |
BG (1) | BG64051B1 (en) |
BR (1) | BR9809519A (en) |
CA (1) | CA2291732C (en) |
DE (1) | DE69809547T2 (en) |
DK (1) | DK0984952T3 (en) |
EE (1) | EE03874B1 (en) |
ES (1) | ES2187030T3 (en) |
HK (1) | HK1025575A1 (en) |
HU (1) | HUP0001878A3 (en) |
ID (1) | ID23794A (en) |
IL (1) | IL133234A (en) |
IS (1) | IS1943B (en) |
MY (1) | MY117960A (en) |
NO (1) | NO995853L (en) |
NZ (1) | NZ501075A (en) |
PL (1) | PL337181A1 (en) |
PT (1) | PT984952E (en) |
RU (1) | RU2193560C2 (en) |
SE (1) | SE510305C2 (en) |
SK (1) | SK282755B6 (en) |
TR (1) | TR199902926T2 (en) |
TW (1) | TW510899B (en) |
UA (1) | UA53720C2 (en) |
WO (1) | WO1998054166A1 (en) |
YU (1) | YU62499A (en) |
ZA (1) | ZA984486B (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE0102886D0 (en) * | 2001-08-29 | 2001-08-29 | Astrazeneca Ab | New formulation |
SE0102888D0 (en) * | 2001-08-29 | 2001-08-29 | Astrazeneca Ab | New formulation |
SE0102887D0 (en) * | 2001-08-29 | 2001-08-29 | Astrazeneca Ab | New formulation |
SE0301795D0 (en) * | 2003-06-19 | 2003-06-19 | Astrazeneca Ab | New use I |
SE0301796D0 (en) * | 2003-06-19 | 2003-06-19 | Astrazeneca Ab | New use II |
ATE528807T1 (en) * | 2006-05-11 | 2011-10-15 | Johnson Controls Saft Advanced Power Solutions Llc | MODULAR BATTERY SYSTEM |
JP5163931B2 (en) * | 2007-03-08 | 2013-03-13 | 株式会社リコー | Fixing apparatus and image forming apparatus |
EP2065385A1 (en) * | 2007-11-28 | 2009-06-03 | Laboratorios SALVAT, S.A. | Stable crystalline salt of (R)-3-fluorophenyl-3,4,5-trifluorobenzylcarbamic acid 1-azabiciyclo [2.2.2]oct-3-yl ester |
CN103833713B (en) * | 2008-11-28 | 2016-02-03 | 中国医学科学院药物研究所 | Nicousamide brilliant type III, its method for making and its pharmaceutical composition and purposes |
SG11201508515WA (en) * | 2013-04-26 | 2015-11-27 | Sanofi Sa | Tartrate salt of 5-chloro-thiophene-2-carboxylic acid [(s)-2-[methyl-3-(2-oxo-pyrrolidin-1-yl)-benzenesulfonylamino]-3-(4-methyl piperazin-1 -yl)-3-oxo-propryl]amide |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5616610A (en) | 1989-12-22 | 1997-04-01 | Astra Aktiebolag | (R)-5-carbamoyl-8-fluoro-3-N,N-disubstituted-amino-3,4-dihydro-2H-1-benzopyrans |
US5420151A (en) * | 1989-12-22 | 1995-05-30 | Aktiebolaget Astra | Chroman derivatives |
IT1282705B1 (en) | 1996-02-28 | 1998-03-31 | Recordati Chem Pharm | USE OF 5-HT | A SEROTONINERGIC RECEPTOR ANTAGONISTS FOR THE TREATMENT OF URINARY INCONTINENCE |
US5990114A (en) | 1996-02-28 | 1999-11-23 | Recordati, S.A., Chemical And Pharmaceutical Company | Use of 5-HT1A receptor antagonists for the treatment of urinary incontinence |
-
1997
- 1997-05-30 SE SE9702066A patent/SE510305C2/en not_active IP Right Cessation
-
1998
- 1998-05-13 TW TW087107397A patent/TW510899B/en active
- 1998-05-15 EP EP98925993A patent/EP0984952B1/en not_active Expired - Lifetime
- 1998-05-15 UA UA99127241A patent/UA53720C2/en unknown
- 1998-05-15 IL IL13323498A patent/IL133234A/en not_active IP Right Cessation
- 1998-05-15 CA CA002291732A patent/CA2291732C/en not_active Expired - Fee Related
- 1998-05-15 AU AU77923/98A patent/AU729301B2/en not_active Ceased
- 1998-05-15 AT AT98925993T patent/ATE228121T1/en not_active IP Right Cessation
- 1998-05-15 YU YU62499A patent/YU62499A/en unknown
- 1998-05-15 SK SK1594-99A patent/SK282755B6/en unknown
- 1998-05-15 US US09/077,718 patent/US6858645B2/en not_active Expired - Fee Related
- 1998-05-15 ES ES98925993T patent/ES2187030T3/en not_active Expired - Lifetime
- 1998-05-15 DK DK98925993T patent/DK0984952T3/en active
- 1998-05-15 NZ NZ501075A patent/NZ501075A/en unknown
- 1998-05-15 BR BR9809519-6A patent/BR9809519A/en not_active IP Right Cessation
- 1998-05-15 WO PCT/SE1998/000907 patent/WO1998054166A1/en not_active Application Discontinuation
- 1998-05-15 EE EEP199900549A patent/EE03874B1/en not_active IP Right Cessation
- 1998-05-15 ID IDW991407A patent/ID23794A/en unknown
- 1998-05-15 DE DE69809547T patent/DE69809547T2/en not_active Expired - Fee Related
- 1998-05-15 JP JP50056099A patent/JP3554338B2/en not_active Expired - Fee Related
- 1998-05-15 CN CNB988056631A patent/CN1198814C/en not_active Expired - Fee Related
- 1998-05-15 PT PT98925993T patent/PT984952E/en unknown
- 1998-05-15 KR KR19997011107A patent/KR20010013127A/en active IP Right Grant
- 1998-05-15 RU RU99128026/04A patent/RU2193560C2/en not_active IP Right Cessation
- 1998-05-15 HU HU0001878A patent/HUP0001878A3/en unknown
- 1998-05-15 PL PL98337181A patent/PL337181A1/en unknown
- 1998-05-15 TR TR1999/02926T patent/TR199902926T2/en unknown
- 1998-05-26 AR ARP980102434A patent/AR012751A1/en unknown
- 1998-05-26 ZA ZA984486A patent/ZA984486B/en unknown
- 1998-05-29 MY MYPI98002400A patent/MY117960A/en unknown
-
1999
- 1999-11-24 IS IS5270A patent/IS1943B/en unknown
- 1999-11-29 NO NO995853A patent/NO995853L/en not_active Application Discontinuation
- 1999-12-03 BG BG103949A patent/BG64051B1/en unknown
-
2000
- 2000-08-08 HK HK00104934A patent/HK1025575A1/en not_active IP Right Cessation
-
2004
- 2004-10-12 US US10/964,388 patent/US20050085532A1/en not_active Abandoned
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100785182B1 (en) | Gabapentin Analogues for Sleep Disorders | |
EP2101772B1 (en) | Intermediate duration neuromuscular blocking agents and antagonists thereof | |
ES2311498T3 (en) | MEDICINAL COMPOSITIONS CONTAINING ASPIRINE. | |
US20070249681A1 (en) | Bupivacaines | |
RU2563821C2 (en) | Application of 4-aminopyridine for improving condition in case of neurocognitive and/or neuropsychiatric disorder in patients with demyelinating and other diseases of nervous system | |
RU2011146032A (en) | 5-HT4 RECEPTOR AGON COMPOUNDS FOR TREATMENT OF COGNITIVE DISORDERS | |
JPH09503777A (en) | Levobupivacaine useful for the treatment of chronic pain | |
RU99128026A (en) | NEW SALT | |
RU2004135563A (en) | MEDICINE FOR TREATING AN INCREASED ACTIVITY OF THE BLADDER | |
MX2007006825A (en) | Preventive or therapeutic agent for sleep disorder. | |
US6326404B1 (en) | Use of O-desmethyl-N-mono-desmethyl-tramadol | |
JPH085787B2 (en) | Dementia and cerebrovascular disorder prophylactic / therapeutic agent and platelet aggregation inhibitor | |
RU2396251C2 (en) | α -AMINOAMIDE DERIVATIVES APPLICABLE AS ANTI-INFLAMMATORY AGENTS | |
RU2004131214A (en) | METHODS FOR TREATING COGNITIVE DISORDERS | |
EP1420782B1 (en) | Use of nefiracetam for treating post-stroke neurodegeneration | |
WO2009053742A2 (en) | Salts of nefopam and their use in therapy | |
US20070088079A1 (en) | Prophylactic or therapeutic agent for sleep disorder | |
JP2008106028A (en) | Use of flibanserin for treatment of chronic pain | |
ES2483940T3 (en) | A new dosage regimen for ionic channel modulating compounds for the treatment of acute atrial fibrillation in a human being | |
JP2001526217A (en) | Novel use of local anesthetics for vascular headache | |
US4686225A (en) | Vinpocetine for pulmonary hemorrhage and edema | |
CN109562180B (en) | Triple combination of a histamine-3 receptor inverse agonist, an acetylcholinesterase inhibitor and an NMDA receptor antagonist | |
JP2003523385A (en) | Treatment of neurodegenerative diseases | |
WO1998038997A1 (en) | Use of levobupivacaine in combination with opiods or alfa2-agonists for providing anaesthesia or analgesia | |
JP2003530350A (en) | Drugs for treating traumatic brain injury and other neuronal disorders |